Adrian Newman-Tancredi

17PUBLICATIONS
25CO-AUTHORS
Sensory systemsNanotoxicology, health and safetyAutonomic nervous systemCheminformatics and quantitative structure-activity relationshipsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 15, 2026
Selective Serotonin-1A Receptor Activation Elicits Antinociceptive Activity in the Knee Osteoarthritis and Plantar Incisional Postoperative Pain Models in Rats.

|Jul 02, 2026
NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson's Disease.

|Sep 01, 2025
[18F]FDG PET metabolic patterns of the rapid-acting antidepressant effects of NLX-101, a 5-HT1A receptor biased agonist.

Sarah Chaib, Elise Levigoureux, Sandrine Bouvard

|Jun 30, 2025
Multimodal Neuroimaging for the PK/PD Profile of NLX-204: A Biased 5-HT1A Receptor Agonist.

Violette Richin, Marco Valdebenito, Caroline Bouillot

|May 27, 2025
Augmentation Therapy With Serotonin 5-HT1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies.

Risa Yamada, Ayumu Wada, Andrew Stickley

|Apr 23, 2025
Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity.

Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki

Pageof 3

Frequent Collaborators

3 joint publications

Luc Zimmer

3 joint publications

Joanna Sniecikowska

3 joint publications

Adam Bucki

3 joint publications

Anna Więckowska